AMBALAL SARABHAI ENT L Share Price

AMBALAL SARABHAI ENT L Share Price

NSE: AMBALALSA
|
Pharmaceuticals
₹ 32.39
-₹0.27 (-0.83%)
1D
Last updated 24 Jul, 2026, 15:29 IST

AMBALAL SARABHAI ENT L Share Price Today

As of 25 Jul 2026, AMBALAL SARABHAI ENT L share price is ₹32.39. The stock opened at ₹33.00, compared to its previous close of ₹32.66. During today's trading session, AMBALAL SARABHAI ENT L share price moved in the range of ₹31.60 to ₹33.00, with an average price of ₹32.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.15 and a high of ₹38.50. On the performance front, AMBALAL SARABHAI ENT L share price has declined by 8.11% over the last six months and is down 8.11% on a year-on-year basis.

₹31.60
0.83% down today
₹33.00
1D LOW
1D HIGH

AMBALAL SARABHAI ENT L Returns Calculator

Circuit
L
H
₹26.13
₹39.19
52-week
L
H
₹30.15
₹38.50
Mkt Cap Cr
250.36
P/E
10.46
P/B
1.17
ROE
11.82%
D/E
0.17
ROCE
11.19%
Div. Yield
0.00%
EPS(TTM)
1.43
Turnover
0.06
EV/EBITDA
8.29
Net Margin
278.93%
Op. Margin
265.23%
ROA
8.25%
Quick Ratio
1.80
Curr. Ratio
1.44
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Ambalal Sarabhai outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Ambalal Sarabhai appears to be fairly valued compared to its peers
Step 5 of 5
Earnings
Excellent
Ambalal Sarabhai revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

AMBALAL SARABHAI ENT L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹202.27₹196.19₹173.57₹170.28
Other Income₹15.17₹11.38₹10.37₹12.49
Total Revenue₹217.44₹207.57₹183.95₹182.77
Total Expenses₹198.54₹196.38₹174.58₹166.91
Profit Before Tax₹18.51₹4.83₹6.65₹15.17
Tax₹0.70-₹0.10₹0.97₹3.72
Profit After Tax₹17.80₹4.93₹5.68₹11.45
EPS - Basic₹2.32₹0.64₹0.74₹1.49
EPS - Diluted₹2.32₹0.64₹0.74₹1.49

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹18.51₹4.83₹6.65₹15.17
Income before WC changes₹15.60₹7.03₹11.12₹14.57
Change in Assets₹2.87-₹38.35₹0.42-₹0.96
Change in Liabilities-₹5.55₹16.91₹1.35-₹3.48
Change in WC-₹2.68-₹21.43₹1.77-₹4.43
Cash flow from Operations₹13.40-₹17.62₹8.89₹5.72
Cash flow from Investing-₹10.25₹13.26-₹5.30-₹16.78
Cash flow from Financing-₹1.85-₹1.52-₹2.95₹9.09
Total Cash Flow₹1.30-₹5.88₹0.65-₹1.97
Cash (Start of the year)₹4.89₹10.78₹10.13₹12.10
Cash (End of the year)₹6.19₹4.89₹10.78₹10.13

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹156.10₹153.08₹130.98₹134.80
Current Assets₹125.03₹118.59₹118.54₹110.94
Total Assets₹281.13₹271.68₹249.52₹245.74
Current Liabilities₹98.54₹120.51₹102.32₹102.87
Net Current Asset₹26.49-₹1.92₹16.23₹8.07
Non-Current Liabilities₹24.22₹11.18₹10.78₹11.94
Equity Capital₹158.36₹139.98₹136.42₹130.93
Total Equity & Liabilities₹281.13₹271.68₹249.52₹245.74

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3.94₹4.04₹3.81₹3.71
Other Income₹15.57₹15.29₹7.89₹10.53
Total Revenue₹19.52₹19.33₹11.70₹14.24
Total Expenses₹9.57₹11.81₹10.89₹9.12
Profit Before Tax₹9.95₹8.08₹0.81₹4.34
Tax-₹1.04-₹0.16-₹1.77₹0.23
Profit After Tax₹10.99₹8.24₹2.58₹4.11
EPS - Basic₹1.43₹1.08₹0.34₹0.54
EPS - Diluted₹1.43₹1.08₹0.34₹0.54

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹9.95₹8.08₹0.81₹4.34
Income before WC changes₹0.20-₹6.15-₹3.16-₹1.37
Change in Assets-₹0.42₹2.33-₹1.91₹2.70
Change in Liabilities-₹2.88₹0.38₹1.93₹0.98
Change in WC-₹3.30₹2.71₹0.02₹3.68
Cash flow from Operations-₹0.26-₹4.08-₹3.82₹1.52
Cash flow from Investing-₹3.02₹6.35₹3.48₹0.61
Cash flow from Financing₹3.40-₹2.31₹0.30-₹3.76
Total Cash Flow₹0.11-₹0.04-₹0.04-₹1.63
Cash (Start of the year)₹0.08₹0.13₹0.17₹1.80
Cash (End of the year)₹0.20₹0.08₹0.13₹0.17

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹44.09₹44.30₹44.79₹45.35
Current Assets₹41.71₹38.62₹36.49₹34.40
Total Assets₹85.79₹82.92₹81.28₹79.74
Current Liabilities₹23.14₹34.12₹40.65₹41.49
Net Current Asset₹18.56₹4.50-₹4.16-₹7.09
Non-Current Liabilities₹3.17₹0.30₹0.34₹0.41
Equity Capital₹59.48₹48.49₹40.29₹37.85
Total Equity & Liabilities₹85.79₹82.92₹81.28₹79.74
* All values are in INR Crore
Qty
Bid
9
32.39
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 9
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
4
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
52.94
Neutral
ATR (14)
1.3
Neutral
STOCH(9,6)
88.38
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
22.14
Bearish
UO(9)
49.29
Neutral
ROC(12)
2.19
Bullish
WillR(14)
-25.07
Neutral
Period
Simple value
Exponential vaue
5D
31.51
31.74
10D
31.37
31.59
20D
31.65
31.71
50D
32.47
31.75
100D
32.48
0

About AMBALAL SARABHAI ENT L

AMBALAL SARABHAI ENT L Share Price
ISIN
INE432A01017
Sector Market Cap
₹ 250.36 Cr

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparations (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in the oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Pvt. Ltd., is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments, distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

AMBALAL SARABHAI ENT L Financial Highlights

  • Revenue: AMBALAL SARABHAI ENT L reported revenue of ₹217.44 crore in FY26 vs ₹207.57 crore in FY25. It showed an increase of 4.76% on a yearly basis.
  • Operating Profit: AMBALAL SARABHAI ENT L reported an operating profit of ₹18.51 crore in FY26 vs ₹4.83 crore in FY25. It showed an increase of 283.23% on a year-on-year basis.
  • Net Profit: AMBALAL SARABHAI ENT L reported a net profit of ₹17.80 crore in FY26 vs ₹4.93 crore in FY25. It showed an increase of 261.05% on a yearly basis.

AMBALAL SARABHAI ENT L Quarterly Result Highlights

  • AMBALAL SARABHAI ENT L reported revenue of ₹68.10 crore in Mar 2026, compared with ₹54.58 crore in Dec 2025, representing an increase of 24.77% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported an operating profit of ₹6.25 crore in Mar 2026, compared with ₹4.36 crore in Dec 2025, representing an increase of 43.35% on a quarter-on-quarter (QoQ) basis.
  • AMBALAL SARABHAI ENT L reported a profit of ₹6.50 crore in Mar 2026, compared with ₹3.64 crore in Dec 2025, reflecting an increase of 78.57% on a QoQ basis.
  • The earnings per share (EPS) of AMBALAL SARABHAI ENT L stood at ₹2.32 during Mar 2026.
Know more
Promoters
31.36%
FII
0.00%
Other DII
0.01%
Retail and other
68.64%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
AMBALAL SARABHAI ENT L Share Price
AMBALAL SARABHAI ENT L
Pharmaceuticals
Add Stock
Add Another

FAQs on AMBALAL SARABHAI ENT L Share Price